Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1992 5
1993 2
1994 5
1996 4
1997 5
1998 5
2000 3
2001 1
2003 1
2004 1
2006 1
2007 1
2010 1
2011 2
2012 3
2014 3
2015 3
2016 2
2018 1
2019 4
2020 2
2021 1
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ; PREVENT Study Group. Wingerchuk DM, et al. Ann Neurol. 2021 Jun;89(6):1088-1098. doi: 10.1002/ana.26049. Epub 2021 Feb 27. Ann Neurol. 2021. PMID: 33586143 Free PMC article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial.
Corboy JR, Fox RJ, Kister I, Cutter GR, Morgan CJ, Seale R, Engebretson E, Gustafson T, Miller AE; DISCOMS investigators. Corboy JR, et al. Lancet Neurol. 2023 Jul;22(7):568-577. doi: 10.1016/S1474-4422(23)00154-0. Lancet Neurol. 2023. PMID: 37353277 Clinical Trial.
Monkeypox-Associated Central Nervous System Disease: A Case Series and Review.
Money KM, Barnett TA, Rapaka S, Osborn R, Kitani T, Fuguet D, Amjad F, Clark JR, Chakravarty D, Copeland MJ, Honce JM, Kumar PN, Kumar RN, Mousa-Ibrahim F, Sirdar B, Sobota R, Tang M, Bolon MK, Russell EJ, Wilson M, Tornatore C, Batra A, Tyler KL, Pastula DM. Money KM, et al. Among authors: tornatore c. Ann Neurol. 2023 May;93(5):893-905. doi: 10.1002/ana.26597. Epub 2023 Jan 27. Ann Neurol. 2023. PMID: 36602053 Review.
A Biophilosophical Approach to the Determination of Brain Death.
Sulmasy DP, DeCock CA, Tornatore CS, Roberts AH 2nd, Giordano J, Donovan GK. Sulmasy DP, et al. Among authors: tornatore cs. Chest. 2024 Apr;165(4):959-966. doi: 10.1016/j.chest.2023.12.011. Chest. 2024. PMID: 38599752 Review.
Intrathecal baclofen in multiple sclerosis: too little, too late?
Erwin A, Gudesblatt M, Bethoux F, Bennett SE, Koelbel S, Plunkett R, Sadiq S, Stevenson VL, Thomas AM, Tornatore C, Zaffaroni M, Hughes M. Erwin A, et al. Among authors: tornatore c. Mult Scler. 2011 May;17(5):623-9. doi: 10.1177/1352458510395056. Epub 2011 Jan 31. Mult Scler. 2011. PMID: 21282321 Free article. Review.
In vivo and in vitro infection of the astrocyte by HIV-1.
Conant K, Tornatore C, Atwood W, Meyers K, Traub R, Major EO. Conant K, et al. Among authors: tornatore c. Adv Neuroimmunol. 1994;4(3):287-9. doi: 10.1016/s0960-5428(06)80269-x. Adv Neuroimmunol. 1994. PMID: 7874397 Review. No abstract available.
67 results